Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial - Ahrén, Bo; Hirsch, Irl B.; Pieber, Thomas R.; Mathieu, Chantal; Gómez-Peralta, Fernando; Hansen, Troels Krarup; Philotheou, Areti; Birch, Sune; Christiansen, Erik; Jensen, Thomas Jon; Buse, John B. (Diabetes care, 2016)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Medicine; Clinical trials; Diabetes; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - drug therapy; Double-Blind Method; Drug dosages; Drug Therapy, Combination; Endocrinology and Diabetes; Endokrinologi och diabetes; Female; Glycated Hemoglobin A - analysis; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents - administration & dosage; Injections, Subcutaneous; Insulin; Insulin - administration & dosage; Klinisk medicin; Liraglutide - administration & dosage; Male; Medical and Health Sciences; Medicin och hälsovetenskap; Middle Aged; Placebo effect; Treatment Outcome; Young Adult